Exagen, Inc. (XGN)
2.95
+0.01
(+0.34%)
USD |
NASDAQ |
May 08, 16:00
2.96
+0.01
(+0.34%)
After-Hours: 20:00
Exagen Research and Development Expense (Annual) : 6.254M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Veracyte, Inc. | 69.17M |
| Insight Molecular Diagnostics, Inc. | 14.66M |
| bioAffinity Technologies, Inc. | 2.089M |
| GRAIL, Inc. | 185.38M |
| FONAR Corp. | 1.576M |